Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMRI to Acquire Cedarburg Pharma | Contract Pharma

What are you searching for?

Sign in
Breaking News

AMRI to Acquire Cedarburg Pharma

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals, Inc., a contract developer and manufacturer of complex API’s, for $38.2 million in cash. The transaction expands AMRI’s position as a supplier of custom and complex drug development services and products to the branded and generic pharma industry.  

Cedarburg, located in Grafton, WI, has expertise in developing technically differentiated APIs, with core capabilities in controlled substances, steroids, prostaglandins, vitamin D analogs, conjugation chemistry and inorganics for the analgesic, ophthalmology and oncology therapeutic areas. Cedarburg’s forecasted 2014 revenue is estimated to be $19 million.  

Cedarburg will continue to operate independently within AMRI’s API business unit. Chuck Boland, currently co-founder and executive vice president of business development will lead the team and report to George Svokos, AMRI’s senior vice president sales and general manager, API.

“We are very excited to be joining efforts with Cedarburg as they bring a unique blend of expertise in complex API, a scalable business infrastructure and extensive customer relationships that will augment our existing capabilities,” said William S. Marth, AMRI’s president and chief executive officer. “This transaction represents an important first step in building out our API capabilities, broadens our offerings and customer base and provides us with an ideal platform to pursue additional value creation opportunities.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics